Current Report · Items 2.02, 9.01 · 8-K

Cannabist Co Holdings Inc.

Results of Operations and Financial Condition

Filed May 8, 2025Accepted May 8, 2025, 5:21 PM EDTCIK 1776738Accession 0001193125-25-116078

Company context

The Cannabist Company, formerly known as Columbia Care, owns subsidiaries that are cultivators, manufacturers and providers of cannabis products and related services, with licenses in 10 U.S. jurisdictions. The Company’s subsidiaries operate 58 facilities including 43 dispensaries and 15 cultivation and manufacturing facilities, including those facilities subject to pending sale or wind-down. Founded as Columbia Care, with a focus on medical applications of cannabis and emphasis on institutional research and clinical outcomes, the Company is one of the original multi-state providers of cannabis in the U.S. and now delivers products and services to both the medical and adult-use markets. In 2021, in response to the proliferation of adult use markets, the Company launched Cannabist, its retail brand, creating a national dispensary network through its subsidiaries. The Company’s subsidiaries offer products spanning flower, edibles, oils and tablets, and manufactures popular brands including dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit www.cannabistcompany.com.

Current securities

CBSTQOTC · EQUITY · Current

Historical securities (1)

CBSTNEO · EQUITY · Historical · closed Jun 18, 2026

Recent company filings

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations

Item 2.02. Results of Operations and Financial Condition. On May 8, 2025, The Cannabist Company Holdings Inc., a British Columbia corporation (the “Company”), issued a press release announcing financial results for the quarter ended March 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K, which is incorporated into this item by reference. The information furnished under this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Filed exhibits (1)

EX-99.1 (by filename) d913291dex991.htm

EX-99.1 2 d913291dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 The Cannabist Company Reports First Quarter 2025 Results Chelmsford, MA, May 8, 2025 - The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the first quarter ended March 31, 2025. All financial information presented in this release is in U.S. GAAP, unaudited, and in thousands of U.S. dollars, unless otherwise noted. First Quarter 2025 Financial Highlights (in $ thousands, excl. margin items): For the Three Months Ended March 31, 2025 December 31, 2024 March 31, 2024 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Revenue $ 87,440 $96,138 $122,611 Gross Profit $ 29,285 …

Open exhibit ↗